F.D.A. Approves Ozempic to Treat Kidney Disease
The Food and Drug Administration on Tuesday approved Ozempic to reduce the risk of serious complications in people who have both Type 2 diabetes and chronic kidney disease. Type 2 diabetes is a leading cause of chronic kidney disease, which affects more than one in seven U.S. adults. The medicationContinue Reading